Through comprehensive smallRNAome sequencing analysis of frontal and temporal cortex tissue samples obtained from FTD patients with mutations in MAPT, GRN, or C9ORF72, we uncovered a consistent down-regulation of miR-129-5p in all investigated brain tissues. The gene discussed is MAPT; the disease is frontotemporal dementia.